Drugs@FDA document
ZYMAR Pediatric Amendment 4 · NDA 021493 SUPPL-9
Drugs@FDA document · ALLERGAN · May 19, 2009
Key facts
| Drug name | ZYMAR |
|---|---|
| Document type | Pediatric Amendment 4 |
| Application | NDA021493 |
| Submission | SUPPL-9 |
| Company | ALLERGAN |
| Document date | May 19, 2009 |
| FDA document | accessdata.fda.gov |
At a glance
- Efficacy-New Patient Population Document categories
- 10–99 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: